Literature DB >> 27803953

Predictive factor for intraoperative tumor rupture of Wilms tumor.

Hiroaki Fukuzawa1, Yuko Shiima2, Yasuhiko Mishima3, Sachi Sekine3, Shizu Miura3, Kiyoaki Yabe3, Satoshi Yamaki3, Keiichi Morita3, Yuichi Okata3, Chieko Hisamatsu3, Makoto Nakao3, Akiko Yokoi3, Kosaku Maeda3, Yoshiyuki Kosaka4.   

Abstract

PURPOSE: For Wilms tumor, intraoperative tumor rupture with wide tumor spillage during surgical manipulation raises the classification to stage 3. Then, postoperative chemotherapy must be more intensive, and abdominal radiotherapy is added. Therefore, intraoperative tumor rupture should be avoided if possible. However, predictive factors for intraoperative tumor rupture have not been sufficiently described. Here we examined the risk factors for intraoperative tumor rupture.
METHODS: Patients with Wilms tumor who underwent treatment according to the National Wilms Tumor Study or the Japanese Wilms Tumor Study protocol at our institution were reviewed retrospectively. Collected cases were categorized into two groups: the ruptured group and the non-ruptured group. Risk factors for intraoperative tumor rupture, including the ratio of the tumor area to the abdominal area in a preoperative single horizontal computed tomography slice (T/A ratio), were investigated in both groups.
RESULTS: The two groups were not different in age, body weight, tumor laterality, sex, or histological distribution. The T/A ratio in the ruptured group was significantly higher than that in the non-ruptured group. Receiver operating characteristic curve analysis identified a discriminative value for a T/A ratio >0.5.
CONCLUSION: The T/A ratio can be a predictive factor for intraoperative tumor rupture of Wilms tumor.

Entities:  

Keywords:  Nephroblastoma; Risk factor; Rupture; Wilms tumor

Mesh:

Year:  2016        PMID: 27803953     DOI: 10.1007/s00383-016-4000-4

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   1.827


  16 in total

1.  Surgical complications after primary nephrectomy for Wilms' tumor: report from the National Wilms' Tumor Study Group.

Authors:  M L Ritchey; R C Shamberger; G Haase; J Horwitz; T Bergemann; N E Breslow
Journal:  J Am Coll Surg       Date:  2001-01       Impact factor: 6.113

2.  Optimal duration of preoperative therapy in unilateral and nonmetastatic Wilms' tumor in children older than 6 months: results of the Ninth International Society of Pediatric Oncology Wilms' Tumor Trial and Study.

Authors:  M F Tournade; C Com-Nougué; J de Kraker; R Ludwig; A Rey; J M Burgers; B Sandstedt; J Godzinski; M Carli; R Potter; J M Zucker
Journal:  J Clin Oncol       Date:  2001-01-15       Impact factor: 44.544

3.  Immediate nephrectomy versus preoperative chemotherapy in the management of non-metastatic Wilms' tumour: results of a randomised trial (UKW3) by the UK Children's Cancer Study Group.

Authors:  Christopher Mitchell; Kathy Pritchard-Jones; Rosemary Shannon; Carolyn Hutton; Suzanne Stevens; David Machin; John Imeson; Anna Kelsey; Gordan M Vujanic; Peter Gornall; Jenny Walker; Roger Taylor; Pat Sartori; Juliet Hale; Gill Levitt; Boo Messahel; Helen Middleton; Richard Grundy; Jon Pritchard
Journal:  Eur J Cancer       Date:  2006-08-10       Impact factor: 9.162

4.  Treatment of Wilms' tumor. Results of the Third National Wilms' Tumor Study.

Authors:  G J D'Angio; N Breslow; J B Beckwith; A Evans; H Baum; A deLorimier; D Fernbach; E Hrabovsky; B Jones; P Kelalis
Journal:  Cancer       Date:  1989-07-15       Impact factor: 6.860

5.  Clinicopathologic findings predictive of relapse in children with stage III favorable-histology Wilms tumor.

Authors:  Peter F Ehrlich; James R Anderson; Michael L Ritchey; Jeffrey S Dome; Daniel M Green; Paul E Grundy; Elizabeth J Perlman; John A Kalapurakal; Norman E Breslow; Robert C Shamberger
Journal:  J Clin Oncol       Date:  2013-02-04       Impact factor: 44.544

Review 6.  Wilms' tumor: status report, 1990. By the National Wilms' Tumor Study Committee.

Authors: 
Journal:  J Clin Oncol       Date:  1991-05       Impact factor: 44.544

7.  Effectiveness of preoperative chemotherapy in Wilms' tumor: results of an International Society of Paediatric Oncology (SIOP) clinical trial.

Authors:  J Lemerle; P A Voute; M F Tournade; C Rodary; J F Delemarre; D Sarrazin; J M Burgers; B Sandstedt; H Mildenberger; M Carli
Journal:  J Clin Oncol       Date:  1983-10       Impact factor: 44.544

8.  Outcome of pediatric renal tumor treated using the Japan Wilms Tumor Study-1 (JWiTS-1) protocol: a report from the JWiTS group.

Authors:  Takaharu Oue; Masahiro Fukuzawa; Hajime Okita; Hideo Mugishima; Hiroshi Horie; Jun-ichi Hata; Masahiro Saito; Miwako Nozaki; Motoaki Chin; Hisaya Nakadate; Shiro Hinotsu; Tsugumichi Koshinaga; Yasuhiko Kaneko; Yoshihiro Kitano; Yukichi Tanaka
Journal:  Pediatr Surg Int       Date:  2009-11       Impact factor: 1.827

Review 9.  Wilms tumour: prognostic factors, staging, therapy and late effects.

Authors:  Sue C Kaste; Jeffrey S Dome; Paul S Babyn; Norbert M Graf; Paul Grundy; Jan Godzinski; Gill A Levitt; Helen Jenkinson
Journal:  Pediatr Radiol       Date:  2007-11-17

Review 10.  Wilms' tumor: diagnosis and treatment in the 1990s.

Authors:  S J Shochat
Journal:  Semin Pediatr Surg       Date:  1993-02       Impact factor: 2.754

View more
  2 in total

1.  Image-based surgical risk factors for Wilms tumor.

Authors:  Takaharu Oue; Akihiro Yoneda; Noriaki Usui; Takashi Sasaki; Masahiro Zenitani; Natsumi Tanaka; Shuichiro Uehara; Soji Ibuka; Yuichi Takama; Hiroomi Okuyama
Journal:  Pediatr Surg Int       Date:  2017-11-08       Impact factor: 1.827

2.  A case report of infantile cystic nephroblastoma.

Authors:  Nozomu Kurose; Michiho Takenaka; Manabu Yamashita; Chie Shimaguchi; Mariko Nakano; Bryant Britni; Xin Guo; Chizuru Futatsuya; Akihiro Shioya; Sohsuke Yamada
Journal:  Diagn Pathol       Date:  2018-10-27       Impact factor: 2.644

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.